| Report ID |
5465 |
| Drug Identification Number |
02103087 |
| Brand name |
BENTYLOL TABLET 10MG |
| Common or Proper name |
Bentylol |
| Company Name |
APTALIS PHARMA CANADA ULC |
| Market Status |
CANCELLED POST MARKET |
| Active Ingredient(s) |
DICYCLOMINE HYDROCHLORIDE |
| Strength(s) |
10MG |
| Dosage form(s) |
TABLET |
| Route of administration |
ORAL |
| Packaging size |
bottle 100 tabs |
| ATC code |
A03AA |
| ATC description |
DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| Reason for shortage |
Other (Please describe in comments) |
| Anticipated start date |
2017-12-20 |
| Actual start date |
|
| Estimated end date |
2017-07-12 |
| Actual end date |
2018-11-19 |
| Shortage status |
Resolved |
| Updated date |
2018-11-26 |
| Company comments |
|
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
Company contact information;
Telephone number: 800-668-6424
Email address: MR-GENERAL_INQUIRY@allergan.com
Website address: allergan.ca
Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
